A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
Couvret C, Laffon M, Baud A, Payen V, Burdin P, Fusciardi J
Anesth Analg 2004;99:262-271.
Review by
An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery.
Slappendel R, Dirksen R, Weber EW, van der Schaaf DB
Acta Orthop Scand 2003;74(5):569-575.
Review by
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.
Henke M, Laszig R, Rube C, et al.
Lancet 2003;362:1255-1260.
Review by